DecisionPoint Financial’s Pfizer PFE Stock Holding History

DecisionPoint Financial’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$932	Buy	+39	New	+$1.02K	﹤0.01%	463
2026 Q1	–	Sell	-168	Closed	-$4.18K	–	716
2025 Q4	$4.18K	Buy	+168	New	+$4.24K	﹤0.01%	266
2025 Q3	–	Sell	-1,500	Closed	-$37.6K	–	671
2025 Q2	$37.6K	Sell	1,500 -1,371	-48%	-$32K	0.01%	95
2025 Q1	$72.8K	Hold	2,871	–	–	0.02%	66
2024 Q4	$76.2K	Buy	2,871 +100	+4%	+$2.71K	0.02%	65
2024 Q3	$80.2K	Hold	2,771	–	–	0.03%	62
2024 Q2	$84.6K	Hold	2,771	–	–	0.03%	62
2024 Q1	$70.4K	Hold	2,771	–	–	0.03%	66
2023 Q4	$79.8K	Sell	2,771 -14	-0.5%	-$423	0.03%	57
2023 Q3	$92.4K	Buy	2,785 +14	+0.5%	+$495	0.05%	39
2023 Q2	$102K	Hold	2,771	–	–	0.05%	36
2023 Q1	$113K	Hold	2,771	–	–	0.07%	32
2022 Q4	$142K	Buy	+2,771	New	+$133K	0.09%	29

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DecisionPoint Financial's PFE Position: Q2 2026 in Review

DecisionPoint Financial opened a new position in Pfizer (PFE) in Q2 2026: 39 shares worth $932. The stake represents ﹤0.01% of the portfolio and ranks #463 among its holdings. This is a return to the name: DecisionPoint Financial previously reported a position in PFE as recently as Q4 2025.

DecisionPoint Financial first reported a position in PFE in Q4 2022 and has held it in 13 quarters since. The position peaked at $142K in Q4 2022. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

DecisionPoint Financial held 39 shares of Pfizer worth $932 as of Q2 2026.
Pfizer was a new DecisionPoint Financial position in Q2 2026.
Pfizer made up ﹤0.01% of DecisionPoint Financial's portfolio in Q2 2026, its #463 holding.
DecisionPoint Financial first reported a position in Pfizer in Q4 2022 and has held it in 13 quarters since.
DecisionPoint Financial's Pfizer position peaked at $142K in Q4 2022.
2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on DecisionPoint Financial's 13F filing for Q2 2026, filed 5 Aug 2026.